Jain Nikunj 4

What Happened

• Jain Nikunj, Principal Accounting Officer at Sangamo Therapeutics (SGMO), surrendered 1,919 shares on May 25, 2026 to satisfy mandatory tax withholding on vested restricted stock units (RSUs). The Form 4 reports the shares as disposed at $0.17/share for a total of $334 (the issuer's closing price used for withholding was $0.1743/share).
• The May 25 vesting installment totaled 2,742 RSU shares; after surrendering 1,919 for taxes, the net shares delivered to the reporting person from that installment were 823.

Key Details

• Transaction date: 2026-05-25; Form 4 filed: 2026-05-27 (timely).
• Reported disposition: 1,919 shares at $0.17/share (total ~$334). Footnote indicates $0.1743/share was the closing price used for withholding.
• Vesting detail: 2,742 shares vested on May 25, 2026; an additional 32,633 shares remain scheduled to vest in 7 equal quarterly installments (per footnote), subject to continuous service and potential acceleration.
• Transaction code: F — shares were surrendered to the issuer for mandatory tax withholding (deemed a disposition for reporting). This is not an open-market sale or discretionary trade.
• Shares owned after the transaction: not specified in the filing.

Context

• This was a routine tax-withholding settlement tied to RSU vesting, not an insider-initiated open-market sale or purchase. Such withholdings are common and generally do not indicate management sentiment about the stock.
• For retail investors, note the filing documents vesting schedule and remaining unvested RSUs; future withholding events or vesting could generate similar reporting.